1-2 of 2
Sophie Salazar
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Remark: A phase II, open-label, multicenter study of orally administered romaciclib (RVU120) for the treatment of anemia in patients with lower-risk myelodysplastic neoplasms (LR-MDS)

Free
Uwe Platzbecker, Elena Crisa, Sophie Salazar, Thomas Cluzeau, Antonella Poloni, Raquel De Paz Arias, Thibault Comont, Sebastian Grosicki, Aristoteles Giagounidis, Matteo Della Porta, Pellegrino Musto, Mar Tormo, Dominic Brauer, Ana Alfonso-Pierola, Stefania Paolini, Sophie Park, Annelies Weyn, Lionel Ades, Valeria Santini
Journal: Blood
Blood (2025) 146 (Supplement 1): 5649.
https://doi.org/10.1182/blood-2025-5649
Published: 2025
Journal Articles

Subgroup analyses from the randomized, Phase 3 VERONA study of venetoclax with azacitidine (Ven+Aza) versus placebo with azacitidine (Pbo+Aza) in patients with treatment-naïve, intermediate and higher-risk Myelodysplastic Syndromes (HR MDS)

Free
Guillermo Garcia-Manero, Uwe Platzbecker, Pierre Fenaux, Gail Roboz, Chun Yew Fong, Marek Hus, Robert Delage, Andrew Brunner, Je-Hwan Lee, Mehmet Turgut, Dominiek Mazure, Yin-Hsun Feng, Yasushi Miyazaki, Zdeněk Kořístek, Sophie Salazar, Stefania Paolini, Maria Diez-Campelo, David Lavie, Dominic Culligan, Grace Ku, Zhijian Xiao, Fang Fang, Maggie Headley, Jalaja Potluri, Amer Zeidan, Jacqueline Garcia
Journal: Blood
Blood (2025) 146 (Supplement 1): 235.
https://doi.org/10.1182/blood-2025-235
Published: 2025